In this study, an attempt has been made to determine the protein binding of ketorolac at different time and concentration in rat model. A total of ten rats were used for this study. The rats were subdivided into two groups and 100µg/ml and 200µg/ml of ketorolac were administered through the intra-peritoneal route to rats of group 1 and group 2, respectively. The serum from the rats were collected and analyzed using UV-VIS spectrophotometry and HPLC. In the UV-VIS Spectrophotometric study, the highest percentage of protein binding for ketorolac was found to be 63.067% in group 1 and 74.63% in group 2. In case of HPLC method, the highest protein binding of ketorolac for group 1 and group 2 were 89.72% and 95.07%, respectively. The observed protein binding percentage of ketorolac by HPLC method was slightly higher than that found in UV-VIS Spectrophotometric method. The result obtained in this study showed that the protein binding of ketorolac changes with the time and drug concentration. The percentage of protein binding was higher for higher drug concentration.
INTRODUCTION
Protein binding refers to the binding of a drug to plasma proteins. The interaction can also occur among the drug and tissue membranes, red blood cells and other components of the blood. The fraction of drugs bound to plasma protein is temporarily inactive. 1 Protein binding is an important parameter to determine the pharmacokinetic and pharmacodynamic properties of drugs. This drug-protein interaction has great impact on bioavailability and toxicity of drugs. [2] [3] [4] [5] Acidic drugs will tend to bind to albumin which are basic and basic drugs will primarily bind to α-glycoprotein, which are acidic. Acidic drugs may also bind to lipoproteins, if the albumin is saturated. 6 Ketorolac is a potent nonsteroidal anti-inflammatory drug that is widely used in the treatment of moderate to severe pain 7 . It is also used in the treatment of post-surgery pain. But it produces gastric and duodenal ulcers. It has been reported that ketorolac produces its analgesic activity by inhibiting prostaglandin synthesis. [8] [9] The aim of the current work was to study the protein binding of Ketorolac to plasma proteins by two different methods, viz -UV spectrophotometry and HPLC and the obtained results were compared.
MATERIALS AND METHODS
Drugs and chemicals. Ketorolac was a kind gift from Incepta Pharmaceuticals Ltd., Bangladesh. All other reagents used were of analytical grade and purchased from the local suppliers. In order to prepare 1000 mL phosphate buffer of pH 7.4, approximately 290 mL of solution A was properly mixed with approximately 66 ml of solution B. Finally the volume was adjusted to 1000 mL by adding demineralized water and the pH was checked by a pH meter.
Preparation
Study design. The study was carried out following a randomized cross-over design. A total of 10 rats were used for the study. For the analysis of ketorolac, the rats were divided into two groups and each group received 100 µg/ml and 200 µg/mL of drug, respectively through intra-peritoneal injection. Then blood samples were taken at 60, 120, 180, 240 and 300 min after administration of each of the doses.
Preparation of rat serum. The blood was collected in a serum tube. The collected serum tube was allowed to settle down for about 1-2 minutes. As soon as the blood clotted, the serum tubes were placed in the centrifuge machine. The blood samples were centrifuged for 10 minutes at 4000 rpm. After the centrifugation process, the serum (supernatant) was collected in a fresh eppendorf tube by a micropipette. Then the serum was stored at -20 °C until further analysis.
Determination of ketorolac in the serum by UV-VIS spectrophotometric technique. Serum sample (50 µl) from each rat of the two groups was taken in separate test tubes. The final volume was adjusted to 5 ml with phosphate buffer solution of pH 7.4. The solutions were then mixed by vortex machine for about 30 seconds. As a control sample, phosphate buffer solution of pH 7.4 and the untreated rat serum was used. The absorbance values of the solutions were determined at 278 nm 11 by a UV spectrophotometer (UV-800, Shimadzu, Japan).
Determination of ketorolac in the serum by HPLC technique. The serum was stored frozen at -20 ºC until analyzed by HPLC machine (model Prominence from Shimadzu, Japan equipped with PDA detector and auto injector). Plasma ketorolac levels were determined as described by FloresMurrieta et al. 12 Briefly, 1 ml serum samples were acidified with 0.2 mL of 0.1 M sodium acetate, at pH 4. This mixture was extracted twice with 5 ml of diethyl ether by agitation with a vortex mixer. Organic layer was transferred to a conical tube and evaporated to dryness at 45 ºC under a stream of nitrogen. The mobile phase was prepared by mixing o-phosphoric acid and acetonitrile in a ratio of 66 : 34 (v/v). The dry residue was redissolved in 1 ml of mobile phase and 200 µl aliquots were injected into the chromatographic system. Separation of the compounds was carried out in 15 cm × 3.9 mm symmetry C18 column of 5µm particle size eluted with a mixture of 10 mM monobasic sodium phosphate adjusted to pH 3 with the mobile phase at a flow rate of 0.7 ml/min. Detection was carried out at 313 nm.
12
Statistical analysis. Results were expressed as Mean ± SD, where applicable.
RESULTS AND DISCUSSION
Determination of protein binding. The amount of drug bound to plasma protein is commonly defined as the percentage bound 13 , which is given by the following formula: The formula determines the fraction of drug present in the plasma and bound to plasma protein. By using this formula, the percentage of protein binding was determined using the free drug concentration in the serum.
Protein binding of ketorolac by UV-VIS spectrophotometric method.
The protein binding of ketorolac to rat serum for both the groups was studied by UV-VIS Spectrophotometric method at pH 7.4 and 37 ºC. Data of UV analysis showed a non-linear curve, suggesting that protein binding of ketorolac changes with time ( Figure 1 and Table 1 ). Figure 4 and Table 1 ). The binding of drugs to plasma proteins, in particular to serum albumin, is a matter of great concern as it can affect the pharmacokinetic properties of the drugs to a great extent. It is the phenomenon which determines the bioavailability of the drugs and the amount of active ingredient available at the site of action. There are various factors that can influence the protein binding of a drug.
The protein binding of ketorolac in rats observed from the above two techniques was compared after intra-peritoneal administration of 100 µg/ml and 200 µg/ml of ketorolac. In this study, the highest protein binding observed for ketorolac by UV-VIS spectrophotometric method was 74.63 % (Figure 1,  panel B) , and it was 95.07% ( Figure 2, panel B) by HPLC method. So, results from both the methods indicated that the percentage of protein binding changed with time. In all the cases, the percentage of protein of binding has an increasing trend in the initial hours after administration. Then the percentage of protein binding started to decrease. Another important phenomenon is that the protein binding is directly proportional to drug concentration. The percentage of protein binding is higher for higher concentration of drugs.
CONCLUSION
Sample serum of rats was analyzed for the determination of protein binding of ketorolac. The highest percentage of protein binding was obtained at the initial hour of administration in all the cases. Both the methods (UV-VIS spectrophotometry and HPLC) showed the same pattern of protein binding.
